Diabetic Nephrology

Diabetic Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Nephropathology and pathogenesis of diabetic nephropathy
  • Contrast nephropathy, uric acid nephropathy
  • Diabetic glomerulosclerosis, IgA nephropathy
  • HIV associated nephropathy
  • Glycemic control, diabetic ketoacidosis

Related Conference of Diabetic Nephrology

May 14-15, 2018

19th Global Nephrologists Annual Meeting

Rome, Italy
July 23-24, 2018

15th International Conference on Nephrology and Hypertension

Kuala Lumpur, Malaysia
October 08-10, 2018

3rd World Kidney Congress

Dubai, UAE
July 23-24, 2018

14th World Nephrology Conference

Melbourne, Australia
October 15-16, 2018

22nd European Nephrology Conference

Warsaw, Poland
October 19-20, 2018

3rd Annual Kidney Congress

New York City, New York, USA
October 19-20, 2018

16th International Conference on Nephrology & Therapeutics

New York City, New York, USA
November 19-21, 2018

International Conference on Nephrology

Cape Town, South Africa
Nov 27-29, 2018

Annual Congress on Nephrology & Hypertension

Athens, Greece

Diabetic Nephrology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in